Peer-reviewedCC BYPharmaceutics
Unraveling Vulnerabilities and Pathways Responsible for AITL Malignancy to Improve Patients’ Treatment
- 1, Institut National de la Santé et de la Recherche Médicale (INSERM), C3M, 06204 Nice, France; (C.M.); (A.K.); (A.P.); (L.B.)
- 2Laboratory of Advanced Genome Editing Technologies, Department Centre for Integrative Biology (CIBIO), , 38122 Trento, Italy;
- 3INSERMU955, Unité Hémopathies Lymphoïdes, Institut Mondor de Recherche Biomédicale, Université Paris-Est Créteil, Hôpitaux Universitaires Henri Mondor, Assistance Publique des Hôpitaux de Paris, 94000 Créteil, France;
Related
- Editorial: Unraveling the molecular web of inflammation and fibrosis: pathways, immune interactions, epigenetics, and therapeutic frontiers
- Spatial Profiling Reveals Immune Escape Pathways and Therapeutic Vulnerabilities in Prostate Cancer Bone Metastases
- Unraveling Lithium Dynamics in Solid Electrolyte Interphase: From Graph Contrastive Learning to Transport Pathways.
- Equity dimensions of future vulnerabilities to climate hazards: Long-term spatial population projections for New York City consistent with Shared Socioeconomic Pathways
- Bisphenol Analog‐Induced Cytotoxicity: Unraveling Endoplasmic Reticulum (ER) Stress and Apoptotic Pathways
BibTeX
@article{martinello2026unraveling,
title = {{Unraveling Vulnerabilities and Pathways Responsible for AITL Malignancy to Improve Patients’ Treatment}},
author = {Chiara Martinello and Adrien Krug and Pau Marin-Escudero and Aurélia Pollet and François Lemonnier and Laurent Boyer and Els Verhoeyen},
journal = {Pharmaceutics},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13708693},
note = {CC BY},
}
RIS
TY - JOUR
TI - Unraveling Vulnerabilities and Pathways Responsible for AITL Malignancy to Improve Patients’ Treatment
AU - Chiara Martinello
AU - Adrien Krug
AU - Pau Marin-Escudero
AU - Aurélia Pollet
AU - François Lemonnier
AU - Laurent Boyer
AU - Els Verhoeyen
PY - 2026
DA - 2026/10/01
JO - Pharmaceutics
UR - https://europepmc.org/article/PMC/PMC13708693
SN - 1999-4923
ER -